Six questions, answered
The questions we hear in every first meeting, one card at a time.
Six questions come up in almost every first meeting. Each card holds one. Flip it for the straight answer, then use the arrows, or swipe, for the next.
What is infinitusbio?
infinitusbio is the Intelligence Company for the Molecule Economy. It predicts whether a drug will work, in which patients, in which diseases and with which partner drug, before money is committed. Its Macro-connectionist Multi-Agent AI digitally clones patients' cells as whole-cell simulations from mRNA data, applies the drug's known on- and off-targets, and reads the result mechanistically.
How is infinitusbio different from other AI drug-discovery companies?
Most AI drug companies design new molecules or train machine-learning models on past trials. infinitusbio does neither. It simulates the cell mechanistically with 200,000+ interacting agents and uses no training data, so it inherits no bias from history, gives the same answer for the same input, and shows the pathway behind every call.
Is an efficacy call from infinitusbio clinical proof?
No. infinitusbio calls efficacy by simulating a drug's effect in patients' cells and reading the mechanism. Efficacy calls are not clinical evidence and do not replace clinical trials or regulatory review. They help decide which trials to run, in whom, and with which partner drug.
What does "deterministic" mean?
infinitusbio runs a deterministic multi-agent simulation, not token prediction. The same input gives the same answer, and nothing is generated that the simulation did not compute, so there are no hallucinations. Every result traces to the molecules and pathways that produced it. A prediction can still be wrong, which is why every market call is sealed and timestamped before the event and scored afterwards.
What is a public read?
A public read is a sealed call on a molecule with a public readout, sold as a report. Orders stay open for a set period. When they close, the price is set within the published estimate and the report goes to every buyer, and to the molecule’s owner, at the same moment, before the readout. No one gets an early look, and the owner may publish a response alongside. After the readout it is revealed free on the Ledger and scored.
What do you need to start a read?
Limited inputs from public or proprietary data are sufficient to digitally clone patient cells and biopsies: the drug's known targets and patient mRNA. No training. Fully auditable. Request your read to start.
Still have a question? Ask the founders directly.

